Proteoliposome-based selection of a recombinant antibody fragment against the human M2 muscarinic acetylcholine receptor

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Volumn 33, Issue 6, 2014, Pages 378-385

  Suharni, ^a   Nomura, Yayoi ^a,b   Arakawa, Takatoshi ^a,b   Hino, Tomoya ^a,b   Abe, Hitomi ^a   Nakada Nakura, Yoshiko ^a,b   Sato, Yumi ^a,b   Iwanari, Hiroko ^c   Shiroishi, Mitsunori ^a,b   Asada, Hidetsugu ^a,b   Shimamura, Tatsuro ^a,b   Murata, Takeshi ^a,b,d   Kobayashi, Takuya ^a,b   Hamakubo, Takao ^c   Iwata, So ^a,b,d,e   Nomura, Norimichi ^a,b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d RIKEN   (Japan)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN FRAGMENT; MUSCARINIC M2 RECEPTOR; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEOLIPID; PROTEOLIPOSOMES; RECOMBINANT PROTEIN;

BIOSYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EVALUATION STUDY; GENETICS; HUMAN; IMMUNOLOGY; KINETICS; METABOLISM; PEPTIDE LIBRARY; SACCHAROMYCES CEREVISIAE; SITE DIRECTED MUTAGENESIS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMANS; IMMUNOGLOBULIN FRAGMENTS; KINETICS; MUTAGENESIS, SITE-DIRECTED; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEOLIPIDS; RECEPTOR, MUSCARINIC M2; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE;

EID: 84920063550     PISSN: None     EISSN: 21679436     Source Type: Journal    
DOI: 10.1089/mab.2014.0041     Document Type: Article

References (30)

1. Fredriksson R, LagerströmMC, Lundin LG, and Schiöth HB: The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 2003;63:1256-1272.
2. Wettschureck N, and Offermanns S: Mammalian G proteins and their cell type specific functions. Physiol Rev 2005;85:1159-1204.
3. Overington JP, Al-Lazikani B, and Hopkins AL: How many drug targets are there? Nat Rev Drug Discov 2006;5: 993-996.
4. Hoogenboom HR: Selecting and screening recombinant antibody libraries. Nat Biotechnol 2005;23:1105-1116.
5. Goletz S, Christensen PA, Kristensen P, Blohm D, Tomlinson I, Winter G, and Karsten U: Selection of large diversities of antiidiotypic antibody fragments by phage display. J Mol Biol 2002;315:1087-1097.
6. Knappik A, Ge L, Honegger A, Pack P, Fischer M, Wellnhofer G, Hoess A, Wö lle J, Plückthun A, and Virnekäs B: Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol 2000; 296:57-86.
7. Peipp M, Simon N, Loichinger A, Baum W, Mahr K, Zunino SJ, and Fey GH: An improved procedure for the generation of recombinant single-chain Fv antibody fragments reacting with human CD13 on intact cells. J Immunol Methods 2001;251:161-176.
8. Schwemmlein M, Peipp M, Barbin K, Saul D, Stockmeyer B, Repp R, Birkmann J, Oduncu F, Emmerich B, and Fey GH: A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells. Br J Haematol 2006;133:141-151.
9. Wess J, Eglen RM, and Gautam D: Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 2007;6:721-733.
10. Asada H, Uemura T, Yurugi-Kobayashi T, Shiroishi M, Shimamura T, Tsujimoto H, Ito K, Sugawara T, Nakane T, Nomura N, Murata T, Haga T, Iwata S, and Kobayashi T: Evaluation of the Pichia pastoris expression system for the production of GPCRs for structural analysis. Microb Cell Fact 2011;10:24.
11. Haga K, Kruse AC, Asada H, Yurugi-Kobayashi T, Shiroishi M, Zhang C, Weis WI, Okada T, Kobilka BK, Haga T, and Kobayashi T: Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 2012;482:547-551.
12. Sambrook J, and Russell DW (Eds.): Molecular Cloning : A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 2001.
13. Barbas CF III, Kang AS, Lerner RA, and Benkovic SJ: Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 1991;88:7978-7982.
14. Barbas CF III, Burton DR, Scott JK, and Silverman GJ: Phage Display: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2001.
15. Ho SN, Hunt HD, Horton RM, Pullen JK, and Pease LR: Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989;77:51-59.
16. Ito K, Sugawara T, Shiroishi M, Tokuda N, Kurokawa A, Misaka T, Makyio H, Yurugi-Kobayashi T, Shimamura T, Nomura N, Murata T, Abe K, Iwata S, and Kobayashi T: Advanced method for high-throughput expression of mutated eukaryotic membrane proteins in Saccharomyces cerevisiae. Biochem Biophys Res Commun 2008;371:841-845.
17. Drew D, Newstead S, Sonoda Y, Kim H, von Heijne G, and Iwata S: GFP-based optimization scheme for the overexpression and purification of eukaryotic membrane proteins in Saccharomyces cerevisiae. Nat Protoc 2008;3:784-798.
18. Shiroishi M, Tsujimoto H, Makyio H, Asada H, Yurugi-Kobayashi T, Shimamura T, Murata T, Nomura N, Haga T, Iwata S, and Kobayashi T: Platform for the rapid construction and evaluation of GPCRs for crystallography in Saccharomyces cerevisiae. Microb Cell Fact 2012;11:78.
19. Kameyama K, Haga K, Haga T, Moro O, and Sadee W: Activation of a GTP-binding protein and a GTP-bindingprotein-coupled by a muscarinic receptor m2 mutant lacking phosphorylation sites. Eur J Biochem 1994;276: 267-276.
20. Hulme E: Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 1990;30:633-673.
21. Day PW, Rasmussen SGF, Masood A, Parnot C, Jose J, Kobilka TS, Yao XJ, Choi HJ, Weis WI, Rohrer DK, and Kobilka BK: A monoclonal antibody for G protein-coupled receptor crystallography. Nat Methods 2007;4:927-929.
22. Rasmussen SGF, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VRP, Sanishvili R, Fischetti RF, Schertler GFX, Weis WI, and Kobilka BK: Crystal structure of the human b2 adrenergic G-protein-coupled receptor. Nature 2007;450:383-387.
23. Jörissen H, Bektas N, Dahl E, Hartmann A, ten Haaf A, Di Fiore S, Kiefer H, Thess A, Barth S, and Klockenbring T: Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer. BMC Cancer 2009;9:200.
24. Hino T, Arakawa T, Iwanari H, Yurugi-Kobayashi T, Ikeda-Suno C, ONakada-Nakura Y, Kusano-Arai O,Weyand S, Shimamura T, Nomura N, Cameron AD, Kobayashi T, Hamakubo T, Iwata S, and Murata T: G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature 2012;482:237-240.
25. Hino T, Iwata S, and Murata T: Generation of functional antibodies for mammalian membrane protein crystallography. Curr Opin Struct Biol 2013;23:563-568.
26. Hunte C, and Michel H: Crystallisation of membrane proteins mediated by antibody fragments. Curr Opin Struct Biol 2002;12:503-508.
27. Koide S: Engineering of recombinant crystallization chaperones. Curr Opin Struct Biol 2009;19:449-457.
28. Lieberman RL, Culver JA, Entzminger KC, Pai JC, and Maynard JA: Crystallization chaperone strategies for membrane proteins. Methods 2011;55:293-302.
29. Jespersen LK, Kuusinen A, Orellana A, Keinänen K, and Engberg J: Use of proteoliposomes to generate phage antibodies against native AMPA receptor. Eur J Biochem 2000;267:1382-1389.
30. Lo AS, Zhu Q, and Marasco WA: Intracellular antibodies (intrabodies) and their therapeutic potential. Handb Exp Pharmacol 2008;181:343-373.